Merck Millipore’s blood typing reagents are made from human or murine monoclonal antibodies and are formulated in low-protein diluents. These monoclonal reagents offer many advantages over polyclonal-based products. These advantages include:
- Highly specific – no risk of contaminating antibodies
- Lot-to-lot consistency
- Low biohazard risk
- IgM antibodies allow direct agglutination, react without the need for an indirect antiglobulin test, and can be used to type cells with a positive direct antiglobulin test.
Merck Millipore offers a wide range of monoclonal blood typing finished reagents compliant with the requirements of the European Directive 98/79/EC. The BIOSCOT® portfolio is supplied in a variety of commercial configurations: finished reagent bulk, unlabelled vials, or private trade dress.
Please contact us if you would like further information on the Merck Millipore product range.
Additional product details can also be found on www.merckmillipore.com